VENLO, The Netherlands–(BUSINESS WIRE)–QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) announced today
that it had posted its 2018 Annual Report on its website at http://financialreport.qiagen.com.

QIAGEN’s Annual Report on Form 20-F for the year ended December 31,
2018, was filed with the U.S. Securities and Exchange Commission (SEC)
on March 6, 2019, a copy of which can be found on the website of the SEC
at www.sec.gov
or in the “Financial Information” section of the “Investors” section of
our website at http://www.qiagen.com/About-Us/Investors/.

QIAGEN will provide printed copies of the 2018 Annual Report to
shareholders free of charge upon request. To obtain a printed copy of
the 2018 Annual Report please contact: IR@qiagen.com.

About QIAGEN

QIAGEN N.V., a Netherlands-based holding company, is the leading global
provider of Sample to Insight solutions that enable customers to gain
valuable molecular insights from samples containing the building blocks
of life. Our sample technologies isolate and process DNA, RNA and
proteins from blood, tissue and other materials. Assay technologies make
these biomolecules visible and ready for analysis. Bioinformatics
software and knowledge bases interpret data to report relevant,
actionable insights. Automation solutions tie these together in seamless
and cost-effective workflows. QIAGEN provides solutions to more than
500,000 customers around the world in Molecular Diagnostics (human
healthcare), Applied Testing (primarily forensics), Pharma (pharma and
biotech companies) and Aca-demia (life sciences research). As of
December 31, 2018, QIAGEN employed approximately 5,000 people in over 35
locations worldwide. Further information can be found at http://www.qiagen.com.

Contacts

John Gilardi
Vice President, Head of Corporate
Communications and Investor Relations
19300 Germantown Road |
Germantown MD 20874 USA
Phone +1-240-686-2222 | Fax +1-240-686-22238
QIAGEN-Str.
1 | 40724 Hilden Germany
Phone +49-2103-29-11711 | Fax
+49-2103-29-21711
ir@qiagen.com

Phoebe Loh
Associate Director Investor Relations
QIAGEN
GmbH | QIAGEN-Str. 1 | 40724 Hilden | Germany
Phone
+49-2103-29-11457 | Fax +49-2103-29-21457
ir@qiagen.com